114 related articles for article (PubMed ID: 1319497)
1. 2-Acetylpyridine thiocarbonohydrazones. Potent inactivators of herpes simplex virus ribonucleotide reductase.
Blumenkopf TA; Harrington JA; Koble CS; Bankston DD; Morrison RW; Bigham EC; Styles VL; Spector T
J Med Chem; 1992 Jun; 35(12):2306-14. PubMed ID: 1319497
[TBL] [Abstract][Full Text] [Related]
2. 2-Acetylpyridine 5-[(dimethylamino)thiocarbonyl]-thiocarbonohydrazone (A1110U), a potent inactivator of ribonucleotide reductases of herpes simplex and varicella-zoster viruses and a potentiator of acyclovir.
Spector T; Harrington JA; Morrison RW; Lambe CU; Nelson DJ; Averett DR; Biron K; Furman PA
Proc Natl Acad Sci U S A; 1989 Feb; 86(3):1051-5. PubMed ID: 2536930
[TBL] [Abstract][Full Text] [Related]
3. Herpes and human ribonucleotide reductases. Inhibition by 2-acetylpyridine 5-[(2-chloroanilino)-thiocarbonyl]-thiocarbonohydrazone (348U87).
Spector T; Harrington JA; Porter DJ
Biochem Pharmacol; 1991 Jun; 42(1):91-6. PubMed ID: 1648925
[TBL] [Abstract][Full Text] [Related]
4. Inactivators of herpes simplex virus ribonucleotide reductase: hematological profiles and in vivo potentiation of the antiviral activity of acyclovir.
Spector T; Lobe DC; Ellis MN; Blumenkopf TA; Szczech GM
Antimicrob Agents Chemother; 1992 May; 36(5):934-7. PubMed ID: 1324641
[TBL] [Abstract][Full Text] [Related]
5. Herpes simplex virus type 1 ribonucleotide reductase: selective and synergistic inactivation by A1110U and its iron complex.
Porter DJ; Harrington JA; Spector T
Biochem Pharmacol; 1990 Feb; 39(4):639-46. PubMed ID: 2154988
[TBL] [Abstract][Full Text] [Related]
6. Potentiation of antiherpetic activity of acyclovir by ribonucleotide reductase inhibition.
Spector T; Averett DR; Nelson DJ; Lambe CU; Morrison RW; St Clair MH; Furman PA
Proc Natl Acad Sci U S A; 1985 Jun; 82(12):4254-7. PubMed ID: 2987969
[TBL] [Abstract][Full Text] [Related]
7. Selective inhibition of herpes simplex virus ribonucleoside diphosphate reductase by derivatives of 2-acetylpyridine thiosemicarbazone.
Turk SR; Shipman C; Drach JC
Biochem Pharmacol; 1986 May; 35(9):1539-45. PubMed ID: 3011019
[TBL] [Abstract][Full Text] [Related]
8. Topical treatment of infection with acyclovir-resistant mucocutaneous herpes simplex virus with the ribonucleotide reductase inhibitor 348U87 in combination with acyclovir.
Safrin S; Schacker T; Delehanty J; Hill E; Corey L
Antimicrob Agents Chemother; 1993 May; 37(5):975-9. PubMed ID: 8390815
[TBL] [Abstract][Full Text] [Related]
9. Peptidomimetic inhibitors of herpes simplex virus ribonucleotide reductase with improved in vivo antiviral activity.
Moss N; Beaulieu P; Duceppe JS; Ferland JM; Garneau M; Gauthier J; Ghiro E; Goulet S; Guse I; Jaramillo J; Llinas-Brunet M; Malenfant E; Plante R; Poirier M; Soucy F; Wernic D; Yoakim C; Déziel R
J Med Chem; 1996 Oct; 39(21):4173-80. PubMed ID: 8863795
[TBL] [Abstract][Full Text] [Related]
10. Herpes simplex virus ribonucleotide reductase mutants are hypersensitive to acyclovir.
Coen DM; Goldstein DJ; Weller SK
Antimicrob Agents Chemother; 1989 Aug; 33(8):1395-9. PubMed ID: 2552912
[TBL] [Abstract][Full Text] [Related]
11. Specific inhibition of herpesvirus ribonucleotide reductase by synthetic peptides.
Dutia BM; Frame MC; Subak-Sharpe JH; Clark WN; Marsden HS
Nature; 1986 May 22-28; 321(6068):439-41. PubMed ID: 3012359
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity studies on synthetic peptides inhibiting herpes simplex virus ribonucleotide reductase.
Gaudreau P; Michaud J; Cohen EA; Langelier Y; Brazeau P
J Biol Chem; 1987 Sep; 262(26):12413-6. PubMed ID: 3040743
[TBL] [Abstract][Full Text] [Related]
13. Ribonucleotide reductase: an important enzyme in the replication of herpes simplex virus type 1 and a target for antiviral chemotherapy.
Prichard MN; Shipman C
Chemotherapy; 1995; 41(5):384-95. PubMed ID: 8521741
[TBL] [Abstract][Full Text] [Related]
14. Ribonucleotide reductase of herpes simplex virus type 2 resembles that of herpes simplex virus type 1.
Averett DR; Furman PA; Spector T
J Virol; 1984 Dec; 52(3):981-3. PubMed ID: 6092726
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of ribonucleotide reductases encoded by herpes simplex viruses.
Spector T
Pharmacol Ther; 1985; 31(3):295-302. PubMed ID: 3035588
[No Abstract] [Full Text] [Related]
16. Synthesis and inhibitory potency of peptides corresponding to the subunit 2 C-terminal region of herpes virus ribonucleotide reductases.
Gaudreau P; Paradis H; Langelier Y; Brazeau P
J Med Chem; 1990 Feb; 33(2):723-30. PubMed ID: 2153825
[TBL] [Abstract][Full Text] [Related]
17. Herpes simplex type 1 ribonucleotide reductase. Mechanism studies with inhibitors.
Spector T; Jones TE
J Biol Chem; 1985 Jul; 260(15):8694-7. PubMed ID: 2991215
[TBL] [Abstract][Full Text] [Related]
18. Ribonucleotide reductase induced by varicella zoster virus. Characterization, and potentiation of acyclovir by its inhibition.
Spector T; Stonehuerner JG; Biron KK; Averett DR
Biochem Pharmacol; 1987 Dec; 36(24):4341-6. PubMed ID: 2825724
[TBL] [Abstract][Full Text] [Related]
19. Structure-activity relationships among alpha-(N)-heterocyclic acyl thiosemicarbazones and related compounds as inhibitors of herpes simplex virus type 1-specified ribonucleoside diphosphate reductase.
Turk SR; Shipman C; Drach JC
J Gen Virol; 1986 Aug; 67 ( Pt 8)():1625-32. PubMed ID: 3016157
[TBL] [Abstract][Full Text] [Related]
20. Differential effect of nucleoside analog triphosphates on ribonucleotide reductases from uninfected and herpes simplex virus-infected HeLa cells.
Nakayama K; Ruth JL; Cheng YC
J Virol; 1982 Jul; 43(1):325-7. PubMed ID: 6287006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]